iifl-logo

Welcure Drugs & Pharmaceuticals Ltd Bonus

0.57
(-3.39%)
Oct 30, 2025|12:00:00 AM

Welcure Drugs CORPORATE ACTIONS

30/10/2024calendar-icon
30/10/2025calendar-icon
PurposeAnnouncement DateBonus DateRecord DateBonus Ratio
Bonus8 Oct 202516 Oct 202516 Oct 20251:10
1:10 Bonus Issue of Equity Shares Trading Members of the Exchange are hereby informed that WELCURE DRUGS & PHARMACEUTICALS LTD, has fixed Record Date for the purpose of Sub-Division and Bonus Issue of Equity Shares of the Company :- DEMATERIALISED SECURITIES - ROLLING SETTLEMENT SEGMENT COMPANY NAME & CODE WELCURE DRUGS & PHARMACEUTICALS LTD (524661) RECORD DATE 16/10/2025 PURPOSE Issue of 01 (One) Bonus Equity Shares of Re.1/- each for every 10 (Ten) Equity Shares of Re.1/- each held. SUB-DIVIDED PAID-UP VALUE W.E.F. 16/10/2025 DR-737/2025-2026 Note: - i. ISIN No. INE331C01017 of Rs.10/- paid up will not be valid for transactions done on the Exchange on or after 16/10/2025. ii. The new ISIN Number for Re. 1/- paid up will be informed to the market by a separate notice. iii. As informed by the company 1,12,35,820 equity shares would be allotted as on 17th October,2025 (Refer attached Companys Letter dated October 09, 2025) (As Per BSE Notice Dated on 13.10.2025) In continuation to the Exchange Notice No. 20251013-18 dated October 13,2025 , inter alia, nforming therein the Record Date fixed on 16.10.2025 for the purpose of Bonus Issue (Ratio: 01:10) by WELCURE DRUGS & PHARMACEUTICALS LTD. (scrip code: 524661). In the Point no. iii of the said Notice, the company had informed the pre Stock Split Bonus shares to be allotted would be 1,12,35,820 Equity Shares of Rs.10/- each. Trading Members are requested to take note that as now informed by the Company Post Stock Split from Rs.10 to Re1/- per share, the Company will Issue and allot 11,23,58,200 Bonus Equity Shares of Re.1/ each on 17th October,2025 (Refer attached Companys Revised Annexure I Final dated October 17, 2025) Trading Members of the Exchange are requested to take note of the same. (As Per BSE Notice Dated on 17.10.2025)

Welcure Drugs: Related News

Welcure Drugs & Pharma Board Clears Bonus Issue, Stock Split, ₹80 Crore QIP

In addition, a 10:1 stock split has been cleared, dividing one equity share of ₹10 each into 10 shares of ₹1 each.

28 Aug 2025|12:40 PM
Read More
Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.